Evidence map›Paper›PMID 37663631›Full record

ArticleThe Pan African medical journal2023

Polio outbreaks in Cameroon following the COVID-19 pandemic.

Andreas Ateke Njoh, Tchokfe Shalom Ndoula Josue Kedakse, Ekoum Eric Mboke, Raoul Nembot, Lele Youmssi Parfait Collins, Adidja Amani, Hassan Ben Bachire, Kabiru Abubakar Gulma, Laurent Cleenewerck De Kiev

Open access · goldAbstract read
In one paragraph

Article in The Pan African medical journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Andreas Ateke NjohExpanded Program on Immunization, Ministry of Public Health, Yaoundé, Cameroon.
Tchokfe Shalom Ndoula Josue KedakseExpanded Program on Immunization, Ministry of Public Health, Yaoundé, Cameroon.
Ekoum Eric MbokeExpanded Program on Immunization, Ministry of Public Health, Yaoundé, Cameroon.
Raoul NembotExpanded Program on Immunization, Ministry of Public Health, Yaoundé, Cameroon.
Lele Youmssi Parfait CollinsWorld Health Organization, Cameroon Country Office, Yaoundé, Cameroon.
Adidja AmaniMinistry of Public Health, Yaoundé, Cameroon.
Hassan Ben BachireMinistry of Public Health, Yaoundé, Cameroon.
Kabiru Abubakar GulmaSchool of Global Health and Bioethics, Euclid University, Bangui, Central African Republic.
Laurent Cleenewerck De KievSchool of Global Health and Bioethics, Euclid University, Bangui, Central African Republic.
Ministry of Public Health · CMUniversity of Bangui · CFWWF Cameroon · CM

Funding

World Health Organization 001
6 · The paper itself

Abstract

Polio is an infectious and disabling life-threatening disease caused by the poliovirus. This disease is prevented through vaccination. Though this viral infection has been eliminated in most parts of the world, a few countries are still endemic to wild poliovirus. In 2020, the World Health Organization (WHO) African Region, including Cameroon, was certified free of wild poliovirus. Some countries recurrently report circulating vaccine-derived poliovirus cases (cVDPV) despite recorded achievements. Also, the risk of importing poliovirus from endemic settings remains, particularly in the context of coronavirus disease (COVID-19). This study aimed to assess the state of polio in Cameroon and identify the situation during COVID-19. A data review was conducted from February to March 2023. Data on polio cases and vaccination coverage per region of Cameroon were reviewed from 2014 to 2022. Data were analyzed with Microsoft Excel, and the results were presented as proportions. The last wild poliovirus was reported in Cameroon in 2014, and the country benefitted from a response. No case of poliovirus was detected in the country from 2015 to 2018. After that, an increasing number of type two cVDPV were reported across 50% of the country's regions from 2019 to 2022. The outbreaks benefitted from responses with various oral polio vaccines, including the type two novel oral polio vaccine (nOPV-2). Though wild polioviruses have been eliminated in most countries, including Cameroon, cVDPV remains a significant problem. There is an urgent need to strengthen disease surveillance and vaccination to prevent cVDPV-2 in this country, particularly in the COVID-19 context.

Indexed as

COVID-19PoliomyelitisPoliovirusBlindnessCameroonDisease OutbreaksHumansPandemicsPoliovirus Vaccine, OralPoliovirus Vaccine, OralCamerooncirculating vaccine-derived poliovirusCOVID-19outbreakPoliovaccine

Identifiers

PMID37663631
PMCPMC10474802
OpenAlexW4381663593

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.